Detalles de la búsqueda
1.
Innovative Approach to Isolate and Characterize Glioblastoma Circulating Tumor Cells and Correlation with Tumor Mutational Status.
Int J Mol Sci
; 24(12)2023 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37373295
2.
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Br J Cancer
; 125(6): 839-845, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253871
3.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
4.
Immunotherapy-induced eczema treated with dupilumab.
J Eur Acad Dermatol Venereol
; 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38084780
5.
Psoriasis caused by pembrolizumab treatment in advanced melanoma: A positive prognostic side effect?
Dermatol Ther
; 34(5): e15050, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34212457
6.
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
Cancers (Basel)
; 15(22)2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001711
7.
Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials.
Eur J Cancer
; 189: 112910, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301718
8.
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study.
Clin Exp Med
; 23(8): 5113-5120, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37634231
9.
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO.
Clin Colorectal Cancer
; 21(3): 220-228, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35304089
10.
A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients.
NPJ Breast Cancer
; 8(1): 33, 2022 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35314692
11.
Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial.
Lancet Oncol
; 11(9): 845-52, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20702138
12.
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients.
Clin Colorectal Cancer
; 20(4): 314-317, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34364814
13.
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest.
Eur J Cancer
; 139: 81-89, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979645
14.
Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases.
Ann Surg
; 249(3): 420-5, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19247029
15.
Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation.
Cancer Chemother Pharmacol
; 58(5): 585-93, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16680463
16.
Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer.
J Clin Oncol
; 20(19): 4006-14, 2002 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12351598
17.
A phase I and pharmacokinetic study of irinotecan given as a 7-day continuous infusion in metastatic colorectal cancer patients pretreated with 5-fluorouracil or raltitrexed.
Clin Cancer Res
; 10(5): 1657-63, 2004 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15014016
18.
MicroRNA signature in metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies.
Clin Colorectal Cancer
; 13(1): 37-45.e4, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24503111
19.
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen.
Clin Colorectal Cancer
; 11(1): 71-6, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21903485
20.
Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational status.
Crit Rev Oncol Hematol
; 78(3): 243-51, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20619672